The Effect in Renal Function and Vascular Decongestion in Type 1 Cardiorenal Syndrome Treated with Two Strategies of Diuretics, a Pilot Randomized Trial.
Jonathan Samuel Chavez-IñiguezMiguel Ibarra-EstradaSergio Sánchez-VillasecaGregorio Romero-GonzálezJorge J Font-YañezAndrés De la Torre-QuirogaAndrés Aranda-G de QuevedoAlexia Romero-MuñózPablo Maggiani-AguileraGael Chávez-AlonsoJuan Gómez-FregosoGuillermo García-GarcíaPublished in: BMC nephrology (2022)
In patients with CRS1 and a high risk of resistance to diuretics, the use of CD compared to SF offers the same results in renal recovery, diuresis, vascular decongestion and adverse events, and it can be considered an alternative treatment. ClinicalTrials.gov with number NCT04393493 on 19/05/2020 retrospectively registered.